CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bloomios Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bloomios Inc
701 Anacapa Street, Suite C
Phone: (805) 222-6330p:805 222-6330 SANTA BARBARA, CA  93101  United States Ticker: XLRCE XLRCE

This company ceased filing statements with the SEC on 3/29/2024.
On 5/3/2024, the Securities and Exchange Commission (SEC) charged BF Borgers CPA PC and its owner, Benjamin F. Borgers, with significant violations of Public Company Accounting Oversight Board (PCAOB) standards across more than 1,500 SEC filings from January 2021 to June 2023. The charges included falsely representing compliance with PCAOB standards to clients, fabricating audit documentation, and inaccurately stating compliance in audit reports. According to the SEC's order, of 369 BF Borgers' clients whose public filings from January 2021 through June 2023 incorporated the firm's audits and reviews, at least 75 percent of the filings incorporated audits and reviews that did not comply with PCAOB standards. The financials in this report may include past audits and reviews conducted by BF Borgers CPA PC that are deemed not compliant with PCAOB standards.

Business Summary
Bloomios, Inc. manufactures, markets and distributes United States hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America, through its wholly owned subsidiary Bloomios Private Label (BPL). BPL is engaged in manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. BPL provides support at each step from custom formulation, order fulfilment, and brand development. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 10 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, topicals, beverages and pet treats. It manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, and topicals.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYesYesYes-

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer MichaelHill 46 11/30/2020 11/30/2020
President, Director, Chief Strategy Officer BarrettEvans 51 6/16/2021 6/16/2021
Chief Financial Officer, Director JohnBennett 62 6/16/2021 6/16/2021

Subsidiaries
Business Name Address City State/Province Country
Bloomios Private Label, LLC 210 Fentress Blvd. Daytona Beach FL United States

Business Names
Business Name
BLMS
Bloomios Inc
Infusionz LLC
4 additional Business Names available in full report.

General Information
Number of Employees: 30 (As of 12/31/2020)
Outstanding Shares: 64,473,246 (As of 11/17/2023)
Shareholders: 197
Stock Exchange: OTC
Federal Tax Id: 880488851


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024